Oncotarget

Research Papers:

Prostate cancer susceptibility gene HIST1H1A is a modulator of androgen receptor signaling and epithelial to mesenchymal transition

Kendra A. Williams, Minnkyong Lee, Jean M. Winter, Derek E. Gildea, Carla Calagua, Natasha L. Curry, Jens Lichtenberg, Huihui Ye and Nigel P.S. Crawford _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2018; 9:28532-28546. https://doi.org/10.18632/oncotarget.25536

Metrics: PDF 625 views  |   HTML 1058 views  |   ?  


Abstract

Kendra A. Williams1, Minnkyong Lee1, Jean M. Winter1, Derek E. Gildea2, Carla Calagua3, Natasha L. Curry1, Jens Lichtenberg1, Huihui Ye3 and Nigel P.S. Crawford1,4

1Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA

2Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA

3Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA

4Current address: Sanofi, Bridgewater, New Jersey, USA

Correspondence to:

Nigel P.S. Crawford, email: nigel.crawford@sanofi.com

Keywords: ATAC-seq; HIST1H1A; neuroendocrine prostate cancer; epithelial mesenchymal transition; Wnt pathway

Received: October 26, 2017     Accepted: May 01, 2018     Published: June 19, 2018

ABSTRACT

In 2018, approximately 165,000 new prostate cancer (PC) cases will be diagnosed, and over 29,000 men will succumb to PC in the U.S. alone. The means of assessing outcome in the clinic are inaccurate, and there is a pressing need to more precisely identify men at risk of aggressive PC. We previously identified HIST1H1A as a susceptibility gene for aggressive PC. HIST1H1A encodes H1.1, a member of the linker histone family that is involved in chromatin organization and compaction. To understand the molecular basis of aggressive PC, we have characterized how germline variation modulates susceptibility to neuroendocrine differentiation, which is a form of aggressive PC. Immunohistochemistry studies revealed that HIST1H1A is over-expressed in normal human prostate tissue compared to prostate adenocarcinoma. Functional characterization of HIST1H1A in prostate LNCaP cells indicated that HIST1HA over-expression increased cell growth, as well as the expression of neuroendocrine and epithelial-to-mesenchymal markers in vitro. Assay for Transposase-Accessible Chromatin (ATAC-seq), which is used to assess chromatin compaction and thus the transcriptional availability of individual genomic regions, demonstrated that H1.1 plays a prominent role in modulating Wnt signaling pathway genes, which are implicated in prostate tumorigenesis. These results demonstrate that HIST1H1A is a modulator of aggressive PC susceptibility.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 25536